Incivek (Telaprevir) Will No Longer be Available for Hepatitis C Patients
August 15, 2014
Vertex to stop selling hepatitis C drug Incivek
In a move that shows how fast things can change in the biotechnology industry, Vertex Pharmaceuticals Inc. has told doctors it will discontinue sales of Incivek, the hepatitis C treatment that was the first drug developed by the Boston company.
Continue reading this entire article: